Rising yuan won't slow China's export boom

China's central bank has guided the yuan about 3% stronger since April to roughly 7.07 per dollar, with market forecasts anticipating a break below 7.00—possibly to 6.60—implying another ~7% appreciation to 2022 levels. Despite the firmer currency, export volumes have risen ~40% since end-2019 while imports are up only ~1%, and exports have supplied more than half of headline real GDP growth over the past two years; on a REER basis the yuan remains weak (near 15-year lows, ~20% down since early 2022). Beijing appears set on managed appreciation while sustaining an export-led growth model, a dynamic that should temper trade tensions but is unlikely to materially erode China's competitiveness given scale, supply-chain dominance and sector examples (e.g., EVs priced ~50% cheaper in China).

Analysis

Market structure: A modest yuan appreciation (3% since April; consensus ~7% further to ~6.60 next year) is unlikely to dent China’s export engine because REER remains ~20% weaker than early-2022 and China’s scale/vertical supply chains (EVs, batteries, solar) compress pass-through of FX into final prices. Winners: large Chinese exporters and upstream suppliers (battery makers, polysilicon, module manufacturers). Losers: non-China producers competing on cost in the same sectors and import-dependent domestic Chinese retailers if RMB firming accelerates.

Risk assessment: Tail risks include a sudden US tariff escalation or renewed onshore capital controls causing a sharp CNH revaluation/devaluation (>10% moves), or a property-sector shock that re-prices domestic credit spreads. Immediate (days): watch USD/CNH through 7.00; short-term (1–6 months): export volumes and PBOC FX intervention cadence; long-term (6–24 months): structural shift to higher-value exports and potential tightening of trade measures. Hidden dependencies: onshore vs offshore liquidity, shipping bottlenecks, and US/EU demand trends.

Trade implications: Implement FX exposure (long CNH via forwards or 12‑month USD/CNH put options at ~6.90 strike sized 0.5–1% NAV) and selective equity exposure to Chinese EV/renewable supply chain names (see BYD/TAN/ASHR). Use pair trades to neutralize global cyclical risk: long Chinese exporters (BYDDF/FXI/ASHR) vs short non-China auto/solar peers (VWAGY/SPWR) to capture cost and scale differentials. Prefer 3–12 month timeframes and staggered entries to average PBOC intervention noise.

Contrarian angles: Consensus fears that a stronger yuan kills exports are overdone because REER and scale matter more than nominal USD/CNY. Markets may underprice the resilience of China’s manufacturing margins; conversely, geopolitical/tariff tail risks are under-appreciated—a small-probability tariff shock would rapidly re-rate exporters. Historical parallel: 2000s sustained export growth despite periodic appreciation; unintended consequence to watch: firmer RMB could pull capital back onshore, compressing onshore bond yields and rerating Chinese equities upward.

Key Decisions for Investors

• Establish a 2% NAV long position in BYD (BYDDF OTC) over 3–9 months as a primary EV/export play; target +30–50% upside if export volumes remain +20–40% YoY, stop-loss 20%.
• Allocate 1–1.5% NAV to FX: buy 12‑month USD/CNH put options (strike ~6.90) or enter equivalent CNH-forward long exposures to capture ~7% expected RMB appreciation; reduce if CNH breaks back above 7.10 on spot liquidity stress.
• Implement a 1–2% NAV pair trade: long ASHR or FXI (industrial/export heavy A-shares) vs short VWAGY (VW AG ADR) or SPWR (U.S. solar installer) to express China supply-chain cost advantage; horizon 6–12 months, rebalance monthly.
• Buy 9–12 month call spreads on TAN (solar ETF) sized 0.5% NAV (buy 25–35% OTM calls, sell nearer OTM) to play structural solar supply chain strength while limiting premium paid.
• Reduce (trim 25–40%) unhedged exposure to Western manufacturers with high-cost footprints competing with China (select autos/solar) over next 3–6 months; redeploy into China supply-chain long positions if USD/CNH closes below 6.95 for two consecutive weeks.